ReviewJournal of personalized medicine2022

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma.

Jeremy A Meier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.